KA
TMO icon

Kintegral Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Kintegral Advisory’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25M Hold
8,473
– – 0.34% 67
2026
Q1 		$4.17M Sell
8,473
-376
-4% -$204K 0.4% 64
2025
Q4 		$5.13M Sell
8,849
-242
-3% -$137K 0.43% 62
2025
Q3 		$4.41M Sell
9,091
-41
-0.4% -$19.1K 0.38% 76
2025
Q2 		$3.71M Sell
9,132
-14
-0.2% -$5.85K 0.34% 83
2025
Q1 		$4.55M Sell
9,146
-31
-0.3% -$16.8K 0.46% 67
2024
Q4 		$4.78M Sell
9,177
-427
-4% -$235K 0.45% 59
2024
Q3 		$5.94M Sell
9,604
-126
-1% -$74.6K 0.55% 50
2024
Q2 		$5.38M Buy
9,730
+2,382
+32% +$1.36M 0.52% 49
2024
Q1 		$4.27M Sell
7,348
-23
-0.3% -$12.9K 0.43% 65
2023
Q4 		$3.92M Sell
7,371
-47
-0.6% -$22.8K 0.43% 63
2023
Q3 		$3.76M Sell
7,418
-4
-0.1% -$2.13K 0.46% 62
2023
Q2 		$3.88M Hold
7,422
– – 0.46% 64
2023
Q1 		$4.28M Sell
7,422
-399
-5% -$225K 0.55% 51
2022
Q4 		$4.31M Buy
+7,821
New +$4.14M 0.57% 56

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kintegral Advisory's TMO Position: Q2 2026 in Review

Kintegral Advisory held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 8,473 shares worth $4.25M. The position accounts for 0.34% of the portfolio, ranked #67.

Kintegral Advisory first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.94M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Kintegral Advisory held 8,473 shares of Thermo Fisher Scientific worth $4.25M as of Q2 2026.
  • Kintegral Advisory left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.34% of Kintegral Advisory's portfolio in Q2 2026, its #67 holding.
  • Kintegral Advisory first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Kintegral Advisory's Thermo Fisher Scientific position peaked at $5.94M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kintegral Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.